Literature DB >> 7418729

Prostaglandin E release by rat medial basal hypothalamus in vitro. Inhibition by melatonin at submicromolar concentrations.

D P Cardinali, M N Ritta, A M Fuentes, M F Gimeno, A L Gimeno.   

Abstract

Melatonin depressed PGE release by rat medial basal hypothalamus (MBH) in vitro at concentrations 10(-8) M or greater. The two-fold increase in PGE release induced by adding 10(-4) M norepinephrine to MBH explants was also impaired by melatonin at micromolar or greater concentrations. These data support the view that melatonin is a physiological inhibitor of PG synthesis in MBH.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418729     DOI: 10.1016/0014-2999(80)90025-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  10 in total

Review 1.  Pineal gland, photoperiodic responses, and puberty.

Authors:  D P Cardinali; M I Vacas
Journal:  J Endocrinol Invest       Date:  1984-04       Impact factor: 4.256

2.  Effects of estradiol on norepinephrine and prostaglandin efflux in medial basal hypothalamus of ovariectomized rats.

Authors:  D P Cardinali; J Fernández Pardal; M F Gimeno; A L Gimeno
Journal:  J Neural Transm       Date:  1982       Impact factor: 3.575

3.  Pineal--related changes in cyclic AMP levels of rat medial basal hypothalamus.

Authors:  E A Morguenstern; M I Vacas; M I Keller Sarmiento; D P Cardinali
Journal:  Experientia       Date:  1984-02-15

4.  Modification by oxazepam of the diurnal variations in brain 125I-melatonin binding sites in sham-operated and pinealectomized rats.

Authors:  Y Anis; I Nir; U Schmidt; N Zisapel
Journal:  J Neural Transm Gen Sect       Date:  1992

5.  The antigonadotrophic effect of melatonin in Syrian hamsters is modulated by prostaglandin.

Authors:  I Nir; U Schmidt; N Zilber
Journal:  J Neural Transm Gen Sect       Date:  1994

Review 6.  Neuroprotective effect of melatonin: a novel therapy against perinatal hypoxia-ischemia.

Authors:  Daniel Alonso-Alconada; Antonia Alvarez; Olatz Arteaga; Agustín Martínez-Ibargüen; Enrique Hilario
Journal:  Int J Mol Sci       Date:  2013-04-29       Impact factor: 5.923

Review 7.  Melatonin Therapy in Patients with Alzheimer's Disease.

Authors:  Daniel P Cardinali; Daniel E Vigo; Natividad Olivar; María F Vidal; Luis I Brusco
Journal:  Antioxidants (Basel)       Date:  2014-04-10

Review 8.  Mechanisms of Melatonin in Alleviating Alzheimer's Disease.

Authors:  Mayuri Shukla; Piyarat Govitrapong; Parichart Boontem; Russel J Reiter; Jutamaad Satayavivad
Journal:  Curr Neuropharmacol       Date:  2017       Impact factor: 7.363

Review 9.  An Assessment of Melatonin's Therapeutic Value in the Hypoxic-Ischemic Encephalopathy of the Newborn.

Authors:  Daniel P Cardinali
Journal:  Front Synaptic Neurosci       Date:  2019-12-10

Review 10.  Melatonin as a Chronobiotic and Cytoprotective Agent in Parkinson's Disease.

Authors:  Santiago Pérez-Lloret; Daniel P Cardinali
Journal:  Front Pharmacol       Date:  2021-04-15       Impact factor: 5.810

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.